Published:
American HealthChoice Announces the First Sales of the OmniBody Scan
FLOWER MOUND, Texas, Nov. 19 /PRNewswire-FirstCall/ -- American
HealthChoice, Inc. (Pink Sheets: AMHI), http://www.americanhealthchoice.com, a
medical services company with medical clinics inTexas andTennessee, is
pleased to announce the first sales of the U.S. FDA approved OmniBody Scan, an
infrared thermal imaging camera that detects patterns of abnormality within
the human body and identifies problems early enough for prevention and
treatment.
"Physicians purchasing these first systems have been trained and more
systems will be sold soon," said Dr. Joseph W. Stucki, CEO. "We are also
pleased to announce that our new and updated web site, explaining the product
and its myriad uses, has been activated at:
http://www.omnibodyscan.com
"AMHI also has signed a distribution agreement covering theState of Texas
for the purchase of a minimum of 15 cameras annually," Dr. Stucki said. "We
have spoken to a number of oncologists who are very excited about the medical
infrared technology we are bringing to the health care sector. I am confident
that we will be successful in negotiating exclusive distribution agreements in
other states,Canada,Mexico and elsewhere."
The OmniBody Scan is a non-invasive tool with no harmful side effects. It
is manufactured exclusively for American HealthChoice by a respected infrared
imaging manufacturer with years of successful experience in this field. "Our
product adheres to the highest standards of thermography. It is easy to use
and offers a very high grade of technology and quality. With its infrared
technology, it allows an oncologist to find cancers, including breast cancer,
years away from becoming a mass large enough to be detected by mammography, CT
scans, MRIs or Ultrasound," Dr. Stucki said.
Thermography uses infrared technology to capture a picture of the body's
image without the use of radiation or invasive technology. Data on the body's
skin temperature is sent to a computer that converts the patterns to images
which are read by a physician looking for abnormalities. As cancer grows, its
need for nutrients increases and this activity causes increases in
temperatures (neoangiogenesis). These temperature variations, caught by the
infrared imaging, can be an early sign of cancer or pre-cancerous activity.
Finally, the Company is pleased to announce that Dr. Trip Chaudhury, M.D.,
Board Certified in Oncology, with practices inBeaumont andHouston, who
completed a dissertation in Medical School on neoangiogenisis, has joined the
Company's Advisory Board. "He is a perfect fit for our Advisory Board," Dr.
Stucki said.
CONTACT:
Dr. J.W. Stucki, CEO
American HealthChoice, Inc.
817/837-8000
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
SOURCE American HealthChoice, Inc.
Copyright © 2009, PRNewswire
Copyright © 2009, NewsBlaze,
Daily NewsTags: ,HEA,MTC,BIO,OTC,CPR,PDT,PER,TX-Am-HealthChoice
_ _
Breast Cancer News
Search News
Daily News
